At Reviva we are focused on developing a drug that targets both the serotonin and dopamine receptor signaling systems to more effectively treat schizophrenia and its comorbid symptoms.” ...

This piqued our interest, and we wanted to specifically understand whether the serotonergic psychedelic DOI, which has a high ...